Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway

Nav

General Info

Geography

Norway (NOR)

Coverage type

Country

Time period covered

01/2016 - 12/2016

Data type

Scientific literature

Keywords

Hepatitis C

Citation

Authors

Wisløff T, White R, Dalgard O, Amundsen EJ, Meijerink H, Løvlie AL, Kløvstad H

Journal

Pharmacoeconomics

Volume

Issue

Pages

591-601

Publication year

2018

Suggested citation

Wisløff T, White R, Dalgard O, Amundsen EJ, Meijerink H, Løvlie AL, Kløvstad H. Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway. Pharmacoeconomics. 2018; 36(5): 591-601.

DOI

10.1007/s40273-017-0604-3

PMID

29396744

GHDx Entry last modified on: Dec 5, 2022

Header sites

Search form

Main menu

Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway

Nav